ERAMET Group: ERAMET announces that it has acquired a

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
113
ERAMET Group: ERAMET announces that it has acquired a controlling interest in Mineral Deposits Limited

Paris, 11 July 2018, 9:00 AM

PRESS RELEASE

ERAMET Group: ERAMET announces that it has acquired a controlling interest in Mineral Deposits Limited

  • ERAMET currently holds a relevant interest in 63.87% of MDL shares
  • The Board of Directors of MDL have unanimously recommended that MDL shareholders accept ERAMET's Offer
  • The Offer is unconditional
  • The Offer period is extended to close at 7:00pm (Sydney time) on 24 July 2018 (unless further extended)

ERAMET announces today that it now holds a relevant interest in 63.87% of the shares of Mineral Deposits Limited ( MDL ) in the framework of its all-cash takeover offer ( Offer ).

On 10 July 2018, the MDL Board of Directors unanimously recommended that MDL shareholders accept the Offer. MDL has also confirmed that each of the MDL Directors intends to accept the Offer in respect of their own shareholding.

The Offer is intended to facilitate the full consolidation of TiZir, the joint-venture held equally by ERAMET and MDL, which operates an integrated mineral sands (titanium dioxide and zircon) business in Senegal and Norway. 

Given ERAMET now holds a controlling interest in MDL, it intends to replace a majority of the members of the MDL Board with its nominees. Further details are set out in ERAMET's Bidder's Statement dated 14 May 2018.

This all-cash transaction at a price of A$1.75 per MDL share, values the equity of MDL (on a fully diluted basis) at approximately A$350 million [1] , i.e. approximatively EUR 220 million.

The Offer period has been automatically extended to close at 7:00pm (Sydney time) on 24 July 2018 (unless further extended), as a result of ERAMET acquiring more than 50% of MDL.

Christel Bories, Chairman and Chief Executive Officer of ERAMET, commented:

" We are very pleased to announce the acquisition of a controlling interest in MDL.

For ERAMET, this is a logical step, in line with its strategy, designed to enable the consolidation of TiZir within its portfolio at a time when the Group is renewing with development projects. By taking control of TiZir, we are giving ourselves the means to simplify the governance and effectively pursue its development within the promising mineral sands sector. It is the right move done at the right time, and we welcome the momentum in this transaction. "

Funding and settlement

The Offer is financed by using ERAMET's existing cash reserves. These funds are immediately available and in excess of the aggregate Offer consideration and associated transaction costs.

The cash consideration is paid to the shareholders who accept the Offer within 7 business days of acceptance.

No conditions

The Offer has been declared unconditional and is not subject to any conditions.

Advisers

ERAMET has engaged Macquarie Capital as financial adviser and Herbert Smith Freehills as legal adviser in relation to the Offer.

The full terms and conditions of the Offer are set out in the Bidder's Statement dated 14 May 2018 as supplemented by the second to ninth Supplementary Bidder's Statements, which are available on the ERAMET website at www.eramet.com/en .          

------------------------

ABOUT ERAMET

ERAMET is one of the world's leading producers of:

  • manganese and nickel, used to improve the properties of steels, mineralised sands (titanium dioxide and zircon),
  • parts and semi-finished products in alloys and high-performance special steels used in industries such as aerospace, power generation and tooling.

ERAMET is also developing activities with strong growth potential, such as lithium extraction and recycling.

The Group employs around 12,600 people in 20 countries. ERAMET is part of Euronext Paris Compartment A.

LEI code: 549300LUH78PG2MP6N64

For more information: www.eramet.com

Follow us with the ERAMET Finance mobile app:

IOS: https://itunes.apple.com/fr/app/eramet-financ...12055?mt=8

Android: https://play.google.com/store/apps/details?id...et.finance

Click on the link below to view ERAMET's 2017 annual report :

http://www.eramet-looking-ahead.com/

FINANCIAL ADVISER TO ERAMET MEDIA CONTACT
Australia Macquarie Capital Campbell Johnson +612 8232 9224   INVESTOR CONTACT   France ERAMET Investor Relations team Tel: +33 1 45 38 38 12 Mobile: +33 6 08 91 34 24 Australia Domestique Jim Kelly +61 412 549 083 jim@domestiqueconsulting.com.au   France Image7 Marie Artzner  Lauranne Guirlinger +33 6 75 74 31 73  +33 6 48 26 21 73 martzner@image7.fr   lguirlinger@image7.fr    

[1]     Based on 200,026,547 shares on a fully diluted basis.

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moore, Schulman & Moore Attorneys Earn Top Honors Again

Updated Category News Views 4

In the realm of family law, consistency in excellence matters just as much as landing a high-stakes stock trade. Moore, Schulman & Moore, APC, a San Diego family law outfit, has grabbed the spotlight yet again with nine of its ace attorneys snagging recognition from the 2027 Super Lawyers roster. A Tradition of Professional Recognition Leading the pack is Erik Moore, a...

Continue Reading
Ingram Mercantile's Aviation Push: SCORE or Sink?

Updated Category News Views 5

Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...

Continue Reading
Zenni and Chase Stokes Foster Student Wellbeing in NYC

Updated Category News Views 3

Picture this: near 300 high schoolers milling around, glancing through shiny new glasses from the Zenni x Chase Stokes collection. In the heart of New York City, these kids are getting a double-dose of care that's all too rare—free vision screenings paired with mental health support. It's the kind of collaboration that shows you what's possible when a company, an actor,...

Continue Reading
NCICU's Digital Boost for NC Transfer Students

Updated Category News Views 4

New Platform Eases the Transfer Struggle They’ve finally cooked up something good for the college crowd in North Carolina. The NCICU, with the NCCCS, has rolled out a platform called Transfer Pathways to simplify students' path from two-year to four-year schools. This ain't just a tweak—it's backed by a hefty $2 million in grants. Hats off to those...

Continue Reading
Armor Health Strengthens Corrections Care with New Leader

Updated Category News Views 4

Fresh Blood in Correctional Healthcare Talk about stepping up where it counts! Armor Health is shaking things up, bringing in Jill Bromley as their new Regional Behavioral Health Director. The name might not ring any bells for the average Joe, but in the world of correctional healthcare, it’s like they've just upgraded from a sedan to a sports car. Armor’s game here...

Continue Reading
Helio Genomics Shakes Up Liver Cancer Detection Strategy

Updated Category News Views 5

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

Continue Reading
Elevest Unveils MADE: Shaping Wealth for Athletes, Artists

Updated Category News Views 4

Turning Talent Into Tangible Wealth Ask any musician or athlete, and they'll tell you—riding those career highs is exhilarating, but financial stability can be a different ballgame. Here comes Elevest Capital with a fresh move meant to set the players right where many falter: long-term ownership. They're rolling out MADE, a new initiative focused on flipping that burst...

Continue Reading
STRATA Showcases Excimer Laser Success in Dermatology

Updated Category News Views 4

The Cutting Edge of Skin Care: STRATA's Spotlight It's not every day you hear about dermatology shaking things up, but STRATA Skin Sciences, Inc. pulled it off with flair at the 2026 Fall Clinical Dermatology Conference in Las Vegas. For 'skin in the game,' these folks are leading the charge with their innovative excimer laser phototherapy approach, shining a fresh light...

Continue Reading
Navigating Career Growth Beyond Job Titles at Webinar

Updated Category News Views 5

Hasn't it ever struck you that job titles often fence people in like some unwanted corral, keeping potential tightly leashed? Well, here's something that might shake up your thoughts a tad. University of Phoenix is teeing up a webinar titled "Beyond The Job Title: Finding Purpose and Recognizing the Value You Bring." Scheduled for October 15, 2026, this is all about...

Continue Reading
Boliden's Q3 2026 Results: What's on the Horizon?

Updated Category News Views 3

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

Continue Reading

Top 5 Most Recently Viewed Articles

Caribou Biosciences Faces Securities Fraud Lawsuit Amid Losses

Updated Category News Views 139

Understanding the Lawsuit Against Caribou Biosciences Investors in Caribou Biosciences, Inc. (NASDAQ: CRBU) are currently facing significant challenges due to alleged misleading statements made by the company regarding its performance and product safety. A shareholder has initiated a class action lawsuit aimed at representing those who purchased CRBU securities between...

Continue Reading
BMO's Belsky Predicts Resilience of US Stocks Amid Volatility

Updated Category News Views 496

BMO's Bullish Outlook on US Stocks Brian Belsky, the Chief Investment Strategist at BMO Capital Markets, continues to maintain a positive outlook on US equities, despite the recent fluctuations in the market. His unwavering confidence comes even as the S&P 500 experiences losses in four out of the last five weeks. Belsky highlights that this downturn has been largely...

Continue Reading
How Is Pain and Suffering Calculated in Personal Injury Cases?

Updated Category Personal Finance Views 36

Pain and suffering is generally calculated by considering how an injury affects a person's physical comfort, emotional well-being, daily activities, and overall quality of life. Unlike medical bills or lost wages, these losses do not have a fixed price, so courts and insurance companies look at the nature and severity of the injury, recovery period, and long-term effects...

Continue Reading
Leap Therapeutics Showcases Financial Progress and Updates

Updated Category News Views 262

Leap Therapeutics: Financial Highlights and Updates Leap Therapeutics, Inc. (NASDAQ: LPTX), a prominent biotechnology firm dedicated to developing innovative immuno-oncology solutions, has recently revealed its financial results for the latest fiscal year. The focus today is not just on their financial performance, but also on the progress of their in-development...

Continue Reading
Tech Stocks Struggle Amid Economic Growth Concerns

Updated Category News Views 47

Current Trends Impacting Tech Stocks US tech stocks are facing significant challenges, reflecting broader worries about economic growth and the unpredictable AI market. Notably, Nvidia's shares have seen a considerable drop, highlighting the potential impacts on the technology sector. As a leading player in AI technologies, Nvidia's substantial loss in market value...

Continue Reading